Cyclosporine in Pancreatitis

Cyclosporine in Pancreatitis Study

Aim of Study

Evaluate cyclosporine as a novel therapy for dogs with insulin-resistant diabetes mellitus and chronic pancreatitis.

There is some evidence in the human literature that chronic pancreatitis may have an underlying immune-mediated etiology and anecdotally, cyclosporine has resulted in improved diabetic control in a dog with chronic pancreatitis as a cause of insulin resistance.

Client Incentives

Qualifying cases will receive Atopica free of charge for the trial period of six weeks.


For more information please contact Dr. Sina Marsilio at